The dried product (47 mg, m.p. 68-70°), homogeneous on t.l.c., was identified as 3,3-dimethylacrylic acid by comparison (i.r., n.m.r.) with an authentic sample. Spec. act. 3.1 x lo8 dpm/mmole. ## ACKNOWLEDGMENTS. We thank Mr. J. J. Ferrer for the i.r. and n.m.r. spectra, and the Consejo Nacional
Synthesis of I-131 labelled 4-iodophenylacetic acid
✍ Scribed by Zoltan Szucs; Mike Sathekge; Biljana Marjanovic-Painter; Judith Wagener; Thato Sello; Carl Wagener; Jan Rijn Zeevaart
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- French
- Weight
- 172 KB
- Volume
- 54
- Category
- Article
- ISSN
- 0022-2135
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Phenylacetate has been reported to have a potent anti‐proliferative and anti‐differentiating effect in haematological malignancies and in solid tumours at non‐toxic concentrations. This study is a preliminary investigation into the potential of 4‐iodophenylacetic acid radiolabelled by ^131^I as a radiopharmaceutical equivalent. The radiolabelling by isotope exchange gave a radiochemical yield of 53±6%, and a radiochemical purity of 97.8±1.2% as qualified by HPLC. The product contained 4% ester by‐product and is suitable for studies in animals. Copyright © 2010 John Wiley & Sons, Ltd.
📜 SIMILAR VOLUMES
## Abstract ^131^I‐Labelled pyronaridine, an antimalarial drug was synthesized and evaluated for its stability and biodistribution in rabbits. We observed that there was >99% yield of the labelled compound as determined by HPLC and radio‐TLC in our study. Dynamic imaging studies in rabbits showed t
## Abstract Methyl‐N‐carbobenzoxy‐β‐^131^I‐D‐alaninate (**2**) was synthesized by the melt method. Partial hydrolysis of compound **2** gave methyl β‐^131^I‐D‐alaninate (**3**). Hydrolysis of **2** with **2** N HCl gave β‐^131^I‐D‐alanine. The ^123^I and ^125^I labelled compounds were synthesized b
## Abstract A method is described for the synthesis, purification and radiolabelling of 2‐{5‐(4‐iodophenyl)pentyl}oxirane‐2‐carboxylic acid (I‐POCA). This new compound was synthesized from 5‐phenyl‐pentylbromide (1), prepared via 5‐phenyl‐1‐pentanol and subsequently converted to diethyl 5‐phenylpen
We examined the therapeutic efficacy of 131 I-labeled murine monoclonal antibody (MAb) PAM4 against human pancreatic cancers carried as xenografts in athymic nude mice. Animals bearing the CaPan1 tumor (0.2 cm 3 ) were either untreated or were given, 131 I-labeled nonspecific Ag8 antibody. By week 7